Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study

References

• Kimura H Yamaguchi Y A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma Cancer 1997 80 1 42 49 9210707
   PubMed Web of Science ®Google Scholar
• Takayama T Sekine T Makuuchi M Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial Lancet 2000 356 9232 802 807 11022927
   PubMed Web of Science ®Google Scholar
• Kono K Takahashi A Ichihara F Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial Clin Cancer Res 2002 8 6 1767 1771 12060615
   PubMed Web of Science ®Google Scholar
• Folkman J Klagsbrun M Angiogenic factors Science 1987 235 4787 442 447 2432664
   PubMed Web of Science ®Google Scholar
• Biron CA Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections Semin Immunol 1998 10 5 383 390 9799713
   PubMed Web of Science ®Google Scholar
• Pfeffer LM Dinarello CA Herberman RB Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons Cancer Res 15 1998 58 12 2489 2499 9635566
   PubMed Web of Science ®Google Scholar
• Sen GC Lengyel P The interferon system. A bird’s eye view of its biochemistry J Biol Chem 1992 267 8 5017 5020 1371992
   PubMed Web of Science ®Google Scholar
• Brem H Gresser I Grosfeld J Folkman J The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis J Pediatr Surg 1993 28 10 1253 1257 7505321
   PubMed Web of Science ®Google Scholar
• Lengyel P Biochemistry of interferons and their actions Annu Rev Biochem 1985 1 251 282
   Google Scholar
• Kurzrock R Rosenblum MG Quesada JR Sherwin SA Itri LM Gutterman JU Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients J Clin Oncol 1986 4 11 1677 1683 3095504
   PubMed Web of Science ®Google Scholar
• Hand A Pelin K Halme M Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines Anticancer Drugs 1993 4 3 365 368 8395259
   PubMed Web of Science ®Google Scholar
• Zarogoulidis P Kioumis I Papanas N The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature J Chemother 2012 24 3 173 177 22759763
   PubMed Web of Science ®Google Scholar
• Wadler S Schwartz EL Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review Cancer Res 1990 50 12 3473 3486 1692761
   PubMed Web of Science ®Google Scholar
• Aapro MS Alberts DS Salmon SE Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay Cancer Chemother Pharmacol 1983 10 3 161 166 6861260
   PubMed Web of Science ®Google Scholar
• Carmichael J Fergusson RJ Wolf CR Balkwill FR Smyth JF Augmentation of cytotoxicity of chemotherapy by human alphainterferons in human non-small cell lung cancer xenografts Cancer Res 1986 46 10 4916 4920 3019517
   PubMed Web of Science ®Google Scholar
• Bonnem EM Alfa interferon: combinations with other antineoplastic modalities Semin Oncol 1987 14 2 Suppl 2 48 60 3296212
   PubMed Web of Science ®Google Scholar
• Mattson K Nea A Concomitant chemotherapy (CT) and interferonalpha (IFN alpha) for SCLC Proc Am Soc Clin Oncol 1995 14 370
   Google Scholar
• Zarogoulidis K Ziogas E Papagiannis A Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial Lung Cancer 1996 15 2 197 205 8882986
   PubMed Web of Science ®Google Scholar
• Thatcher N Cerny T Stout R Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer Cancer 1987 60 10 2382 2387 2822217
   PubMed Web of Science ®Google Scholar
• Thatcher N Qian W Clark PI Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial J Clin Oncol 2005 23 33 8371 8379 16293867
   PubMed Web of Science ®Google Scholar
• Rossi A Di Maio M Chiodini P Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data J Clin Oncol 2012 30 14 1692 1698 22473169
   PubMed Web of Science ®Google Scholar
• McCracken JD Janaki LM Crowley JJ Concurrent chemotherapy/ radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study J Clin Oncol 1990 8 5 892 898 2159055
   PubMed Web of Science ®Google Scholar
• Jett JR Maksymiuk AW Su JQ Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer J Clin Oncol 1994 12 11 2321 2326 7964947
   PubMed Web of Science ®Google Scholar
• Pohl WR Interferon therapy of the lung and locoregional therapy in pulmology Wien Med Wochenschr 1993 143 16–17 450 454 7505989
   PubMedGoogle Scholar
• Malmberg KJ Levitsky V Norell H IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism J Clin Invest 2002 110 10 1515 1523 12438449
   PubMed Web of Science ®Google Scholar
• Tanio Y Watanabe M Osaki T High sensitivity to peripheral blood lymphocytes and low HLA-class I antigen expression of small cell lung cancer cell lines with diverse chemo-radiosensitivity Jpn J Cancer Res 1992 83 7 736 745 1325431
   PubMedGoogle Scholar
• Gutterman JU Cytokine therapeutics: lessons from interferon alpha Proc Natl Acad Sci U S A 1994 91 4 1198 1205 8108387
   PubMed Web of Science ®Google Scholar
• Wagstaff J Smith D Nelmes P Loynds P Crowther D A phase I study of recombinant interferon gamma administered by sc injection three times per week in patients with solid tumours Cancer Immunol Immunother 1987 25 1 54 58 3109738
   PubMed Web of Science ®Google Scholar
• Fischer JR Schindel M Stein N Selective suppression of cytokine secretion in patients with small-cell lung cancer Ann Oncol 1995 6 9 921 926 8624296
   PubMed Web of Science ®Google Scholar
• DeSantis C Naishadham D Jemal A Cancer statistics for African Americans, 2013 CA Cancer J Clin 2013 5 63 3 151 66 23386565
   PubMed Web of Science ®Google Scholar